MARKET

ICLR

ICLR

ICON PLC
NASDAQ
323.46
+10.36
+3.31%
After Hours: 323.26 -0.2 -0.06% 17:11 07/26 EDT
OPEN
314.01
PREV CLOSE
313.10
HIGH
325.10
LOW
312.85
VOLUME
908.60K
TURNOVER
0
52 WEEK HIGH
347.72
52 WEEK LOW
221.20
MARKET CAP
26.79B
P/E (TTM)
39.25
1D
5D
1M
3M
1Y
5Y
1D
Icon Price Target Cut to $350.00/Share From $355.00 by Barclays
Dow Jones · 9h ago
Icon Is Maintained at Overweight by Barclays
Dow Jones · 9h ago
Barclays Maintains Overweight on Icon, Lowers Price Target to $350
Benzinga · 9h ago
3 Medical Services Industry Stocks to Buy as Healthcare Wage Increases
NASDAQ · 11h ago
Icon Price Target Raised to $383.00/Share From $367.00 by Truist Securities
Dow Jones · 11h ago
Icon Is Maintained at Buy by Truist Securities
Dow Jones · 11h ago
Truist Securities Maintains Buy on Icon, Raises Price Target to $383
Benzinga · 12h ago
ICON Second Quarter 2024 Earnings: Misses Expectations
ICON's revenue missed analyst estimates by 1.0%. The company's shares are down 4.5% from a week ago. Revenue is forecast to grow 6.9% in the next 3 years. The company has reported disappointing results for the second quarter of 2024. ICON missed its revenue and earnings estimates by 27%.
Simply Wall St · 12h ago
More
About ICLR
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.

Webull offers ICON PLC stock information, including NASDAQ: ICLR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ICLR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ICLR stock methods without spending real money on the virtual paper trading platform.